Despite the challenges in studying recurrent implantation failure, progress is currently being made in therapeutic options to help those who suffer from recurrent implantation failure. Three of the most promising therapeutic options for recurrent implantation failure include immune therapies such as peripheral blood mononuclear cells, platelet rich plasma and subcutaneous granulocyte-colony stimulating factor.

中文翻译：

---

治疗复发性植入失败的新治疗选择

尽管在研究复发性植入失败方面存在挑战，但目前在治疗选择方面正在取得进展，以帮助那些患有复发性植入失败的人。复发性植入失败的三种最有希望的治疗选择包括免疫疗法，例如外周血单核细胞、富含血小板的血浆和皮下粒细胞集落刺激因子。